Buchi J Kevin
- SEC CIK
- 0001209726
No open-market purchases or sales filed in the past year.
Current role at each company
- AMRX Amneal Pharmaceuticals, Inc.Directoras of Sep 21, 2026
- BNTC Benitec Biopharma Inc.Directoras of Jun 30, 2026
- AMPE Ampio Pharmaceuticals, Inc.Directoras of Jun 13, 2023
- DRNA Dicerna Pharmaceuticals IncDirectoras of Dec 29, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Buchi J Kevin as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BNTC Benitec Biopharma Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2023 (view filing) | Aug 11 | 3 days | Buchi J KevinDirector | PPurchase | +51.8K | – | – | +18,244.0%52.1K after | |
| Aug 14, 2023 (view filing) | Aug 11 | 3 days | Buchi J KevinDirector | PPurchase | +51.8K | – | – | –51.8K after | Derivative |
AMPE Ampio Pharmaceuticals, Inc.
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 13, 2023 (view filing)12:07 PM ET | Jun 9 | 4 days | Buchi J KevinDirector | PPurchase | +21.9K | $0.2875 | +$6.28K | +17.5%146.9K after | |
| Jun 9, 2023 (view filing)2:26 PM ET | Jun 8 | 1 day | Buchi J KevinDirector | PPurchase | +25.0K | $0.296 | +$7.40K | +25.0%125.0K after | |
| May 17, 2023 (view filing)4:25 PM ET | May 16 | 1 day | Buchi J KevinDirector | PPurchase | +32.5K | $0.2743 | +$8.92K | +48.2%100.0K after | |
| May 16, 2023 (view filing)3:30 PM ET | May 12-15 | 4 days | Buchi J KevinDirector | PPurchase | +67.5K | $0.2426 | +$16.4K | New position67.5K after | 2 lots |